Ketoprofen (Ketofen)

Ketoprofen, marketed under the veterinary brand name Ketofen, is a non-steroidal anti-inflammatory drug (NSAID) that has established use in veterinary medicine for pain and inflammation management in horses, dogs, and cats. In rabbit medicine, ketoprofen is used extra-label as an alternative NSAID, typically in situations requiring short-term pain management or when the preferred first-line medication, meloxicam, is not suitable. Ketoprofen is particularly notable for its availability as an injectable formulation, making it useful for immediate pain control in clinical settings.

Ketoprofen works by inhibiting cyclooxygenase (COX) enzymes, blocking the production of prostaglandins that mediate inflammation, pain, and fever. This mechanism is shared with other NSAIDs including meloxicam and carprofen. Ketoprofen demonstrates potent analgesic and anti-inflammatory effects, often providing rapid onset of pain relief. Some research suggests ketoprofen may have particularly strong effects on certain types of inflammatory mediators, though the clinical significance of these differences in rabbits is not fully established.

The medication is available in injectable form (Ketofen 10% or similar preparations) commonly used in veterinary practice for immediate pain control, as well as oral formulations. For rabbit use, the injectable form may be administered subcutaneously by veterinarians for acute pain situations, while oral formulations or compounded preparations may be dispensed for continued home treatment. The injectable formulation allows for precise dosing without the need for pill crushing or palatability concerns.

While ketoprofen can be effective for pain management in rabbits, meloxicam remains the preferred NSAID for this species due to more extensive safety data and clinical experience. Ketoprofen is typically reserved for short-term use, situations where injectable administration offers advantages, or cases where meloxicam is contraindicated. As with all NSAIDs used in rabbits, ketoprofen requires careful veterinary supervision, appropriate dosing, and monitoring for potential gastrointestinal and renal effects. The medication should only be used under the guidance of a rabbit-savvy veterinarian who can evaluate whether ketoprofen is appropriate for your individual rabbit.

The primary indications for ketoprofen in rabbits involve acute pain and inflammation management, with the medication often selected for its injectable formulation's convenience in clinical settings. While meloxicam remains the first-line NSAID for rabbits, ketoprofen provides a valuable alternative when injectable administration offers advantages or when short-term, intensive pain management is needed. Understanding the appropriate use cases helps ensure ketoprofen is employed effectively.

Post-surgical pain management represents one of the most common applications for ketoprofen in rabbit medicine. Procedures such as spays, neuters, dental extractions, tumor removals, and orthopedic surgeries cause significant pain that benefits from immediate anti-inflammatory therapy. The injectable formulation allows veterinarians to provide pain relief during the recovery period immediately following anesthesia, before the rabbit is able to take oral medications. This ensures continuous pain control during the critical early post-operative period.

Acute musculoskeletal pain from injuries, sprains, or sudden onset of painful conditions may prompt ketoprofen use. When a rabbit presents with acute pain requiring immediate intervention, injectable ketoprofen provides rapid onset of analgesia. Injuries from falls, rough handling, or interactions with other animals may cause significant pain that benefits from prompt anti-inflammatory treatment. Ketoprofen's potent analgesic action makes it useful for these acute situations.

Dental pain associated with common rabbit dental problems including molar spurs, abscesses, or tooth root issues responds to NSAID therapy. Rabbits with dental disease often show dramatic improvement in appetite and comfort with adequate pain management. While meloxicam is typically preferred for ongoing dental pain management, ketoprofen may be used for initial treatment, particularly if injectable administration is advantageous for a rabbit that is not yet eating.

Other acute inflammatory conditions affecting various body systems may benefit from short-term ketoprofen therapy. Conditions causing sudden onset of pain or inflammation, whether from infection, trauma, or other causes, can be managed with ketoprofen while definitive diagnosis and treatment are pursued. The medication provides symptomatic relief but does not treat underlying causes, which must be addressed through appropriate specific therapy.

Dosing of ketoprofen in rabbits requires careful veterinary calculation, as rabbit doses differ from those used in dogs, cats, and horses for which the medication is approved. General dosing guidelines for rabbits suggest 1 to 3 mg/kg administered subcutaneously or orally, typically once daily. However, the specific dose for your rabbit must be determined by your rabbit-savvy veterinarian based on the clinical situation, your rabbit's weight and health status, and whether the medication is being used for initial treatment or ongoing management.

Accurate weight measurement is essential for safe ketoprofen dosing in rabbits. Your rabbit should be weighed using a gram scale for maximum precision, particularly for smaller rabbits where minor weight variations significantly affect the calculated dose. The veterinarian will use this weight to determine the exact amount of medication needed. For injectable administration, the veterinarian calculates the precise volume to draw from the medication vial. For oral formulations, compounded preparations may be prescribed to allow accurate measurement.

Treatment duration with ketoprofen in rabbits is typically shorter than with some other NSAIDs, reflecting the medication's common use for acute rather than chronic pain management. Many protocols recommend limiting ketoprofen use to 3 to 5 days when possible, though specific duration depends on the clinical situation. For post-surgical pain, treatment often continues for 3 to 7 days depending on the procedure and individual rabbit's recovery. Longer-term use requires careful monitoring for adverse effects.

Administration route depends on the formulation and clinical circumstances. Injectable ketoprofen is typically administered subcutaneously (under the skin) by the veterinarian and provides rapid onset of pain relief. This route is particularly useful when immediate pain control is needed or when the rabbit cannot take oral medication. For continued home treatment following initial injectable doses, oral formulations or compounded preparations may be dispensed with specific instructions for administration.

If oral ketoprofen is prescribed, administration techniques are similar to other oral medications for rabbits. Compounded liquids can be administered directly via oral syringe, or the medication can be mixed with a small amount of palatable food. Tablets, if used, must be crushed and carefully portioned due to dose size differences between dog and rabbit patients.

Missed doses should be handled according to your veterinarian's specific instructions. Generally, if a dose is missed, it should be given when remembered unless the next scheduled dose is approaching. Never double dose to compensate for a missed administration. Because ketoprofen is typically used for short-term therapy, missed doses may warrant contact with your veterinarian to discuss the treatment plan.

Ketoprofen carries the potential for side effects common to the NSAID drug class, with gastrointestinal and renal effects being the primary concerns. While many rabbits tolerate short courses of ketoprofen without significant problems, awareness of potential adverse effects allows for appropriate monitoring and early intervention if problems develop. The emphasis on short-term use of ketoprofen in rabbits reflects efforts to minimize cumulative side effect risks.

Gastrointestinal effects are the most common concerns with ketoprofen and other NSAIDs in rabbits. These medications can cause gastrointestinal irritation, reduced appetite, and in severe cases, gastric ulceration. Signs to monitor include decreased appetite, changes in fecal pellet size or quantity, softer than normal stool, reduced water consumption, and signs of abdominal discomfort such as hunched posture, reluctance to move, or teeth grinding. Because maintaining gut function is critical for rabbit health, any significant change in eating or fecal output during ketoprofen treatment requires veterinary attention.

Renal (kidney) effects represent another significant consideration with ketoprofen use. All NSAIDs can reduce blood flow to the kidneys through their effects on prostaglandins, potentially causing acute kidney injury. This risk is increased in dehydrated rabbits, those with pre-existing kidney compromise, and during prolonged use. Signs that might indicate kidney problems include changes in urination frequency or volume, increased or decreased thirst, lethargy, and appetite loss. Maintaining adequate hydration during ketoprofen treatment is essential.

Injection site reactions may occur when ketoprofen is administered subcutaneously, though this is typically mild. Some rabbits may show transient sensitivity at the injection site. Severe or persistent swelling, heat, or pain at the injection site should be reported to your veterinarian. Most injection site reactions resolve without intervention within a day or two.

Serious adverse effects requiring immediate veterinary attention include complete refusal to eat for more than 12 hours, absence of fecal pellets for more than 12 hours, severe lethargy or weakness, signs of gastrointestinal bleeding (dark or bloody stool), or collapse. While serious reactions are uncommon with appropriate short-term use, prompt recognition and intervention improve outcomes if they occur. Any rabbit receiving ketoprofen should be monitored closely throughout treatment.

Known hypersensitivity or previous adverse reaction to ketoprofen or other NSAIDs constitutes an absolute contraindication to use. Rabbits that have experienced gastrointestinal problems, kidney issues, or other adverse effects with any NSAID should not receive ketoprofen without careful veterinary evaluation. Cross-reactivity between different NSAIDs is possible, so history of problems with meloxicam, carprofen, or other anti-inflammatory medications should be disclosed before ketoprofen is prescribed.

Pre-existing kidney disease or renal insufficiency contraindicates ketoprofen use in most circumstances. The medication's effects on renal blood flow can exacerbate existing kidney compromise and potentially precipitate acute kidney failure. Rabbits with elevated kidney values on blood work, history of kidney problems, clinical signs of kidney disease, or significant dehydration should not receive ketoprofen. Alternative pain management strategies should be discussed with your veterinarian for rabbits with renal concerns.

Active gastrointestinal problems including GI stasis, known ulceration, or significant gut motility issues contraindicate ketoprofen use. NSAIDs can worsen gastrointestinal inflammation and increase ulcer risk, making them inappropriate when gut health is already compromised. Rabbits who are not eating normally should have GI function addressed before NSAID therapy is considered, and alternative pain management may be needed during GI recovery.

Hepatic (liver) dysfunction may contraindicate ketoprofen use, as the medication is metabolized by the liver. Rabbits with known liver disease, elevated liver enzymes, or other evidence of hepatic compromise may process ketoprofen abnormally, increasing the risk of adverse effects. Your veterinarian will evaluate liver status when determining whether ketoprofen is appropriate.

Pregnancy and nursing generally contraindicate NSAID use including ketoprofen. NSAIDs can affect fetal development and may interfere with labor and delivery processes. The safety of ketoprofen in pregnant or nursing rabbits has not been established. If pain management is needed in pregnant or nursing does, alternative approaches should be discussed with your veterinarian. Concurrent use of corticosteroids or other NSAIDs also contraindicates ketoprofen use due to dramatically increased risk of gastrointestinal complications.

Ketoprofen has several potential drug interactions that must be considered when developing treatment plans for rabbit patients. Complete disclosure of all medications, supplements, and treatments your rabbit is receiving is essential before ketoprofen is prescribed. Your veterinarian will evaluate potential interactions and modify the treatment approach as needed to ensure safety.

Concurrent use with other NSAIDs is strictly contraindicated due to additive risks for gastrointestinal and renal toxicity. This includes meloxicam, carprofen, aspirin, and any other non-steroidal anti-inflammatory medications. Rabbits should never receive multiple NSAIDs simultaneously. If switching from one NSAID to another, adequate washout time (typically several days) should elapse between medications. Always disclose recent NSAID use before ketoprofen is administered.

Corticosteroid medications (prednisone, prednisolone, dexamethasone) should not be combined with ketoprofen due to dramatically increased risk of gastrointestinal ulceration and bleeding. This combination is considered high-risk across species and should be avoided in rabbits. If both anti-inflammatory and corticosteroid therapy might be beneficial, the veterinarian will typically select one approach and monitor carefully rather than combining the two drug classes.

Certain antibiotics may interact with ketoprofen through various mechanisms including competition for protein binding or additive effects on kidney function. Aminoglycoside antibiotics are of particular concern due to increased nephrotoxicity risk when combined with NSAIDs. Many commonly used rabbit-safe antibiotics including enrofloxacin, trimethoprim-sulfa, and metronidazole can generally be used with ketoprofen under appropriate monitoring, but potential interactions should be evaluated.

Diuretics and cardiac medications may interact with ketoprofen through effects on kidney function and electrolyte balance. NSAIDs can reduce the efficacy of certain diuretics and increase kidney stress when combined with some cardiovascular drugs. Rabbits receiving any cardiac or blood pressure medications require careful evaluation before ketoprofen administration.

Anticoagulant or blood-thinning medications may interact with ketoprofen, as NSAIDs can affect platelet function and bleeding time. While rabbits rarely receive anticoagulant therapy, this interaction is important if such medications are being used. Supplements with blood-thinning properties, such as high-dose fish oil, should also be disclosed.

Several important precautions guide safe ketoprofen use in rabbit patients, beginning with recognition of its role as an alternative rather than first-line NSAID. Meloxicam remains the preferred NSAID for rabbits due to more extensive safety data in this species. Ketoprofen is most appropriate for short-term use, situations where injectable administration offers significant advantages, or cases where meloxicam cannot be used. Your rabbit-savvy veterinarian can determine when ketoprofen is the appropriate choice.

Pre-treatment evaluation should include assessment of your rabbit's overall health, hydration status, and organ function. For anything beyond very short-term use, baseline blood work to evaluate kidney and liver parameters is advisable. This provides important safety information and allows comparison if problems develop during treatment. Rabbits that are dehydrated, debilitated, or have concerning baseline parameters may not be suitable candidates for ketoprofen.

Hydration maintenance during ketoprofen treatment is critically important because dehydration significantly increases the risk of NSAID-related kidney damage. Ensure your rabbit has constant access to fresh water and encourage fluid intake through water-rich vegetables. If your rabbit's water consumption decreases or if illness is affecting oral intake, contact your veterinarian. Subcutaneous fluid administration may be needed to maintain adequate hydration in rabbits who are not drinking well.

Monitoring during ketoprofen treatment should include at least twice-daily assessment of appetite, fecal output, activity level, and water consumption. Because ketoprofen is often used for short-term acute pain management, close observation is particularly important during the brief treatment period. Any reduction in eating or fecal production, changes in behavior, or development of new symptoms should prompt veterinary contact. Treatment duration should be limited as much as clinically appropriate.

Special caution is warranted for geriatric rabbits, who are more likely to have reduced kidney or liver function affecting drug handling. Very young rabbits have immature metabolic systems and may also require modified approaches. Dwarf breeds need particularly precise dosing given their small size, while giant breeds require appropriate dose scaling. Rabbits with any concurrent health conditions should be carefully evaluated before ketoprofen is prescribed.

Proper storage of ketoprofen maintains medication stability and ensures accurate potency throughout the treatment period. Storage requirements vary depending on the formulation, so following specific instructions for your prescribed product is important. Improper storage can result in reduced medication effectiveness or altered safety profiles.

Injectable ketoprofen solutions (such as Ketofen 10%) are typically stored at controlled room temperature, between 68°F and 77°F (20°C to 25°C), protected from light and freezing. Multi-dose vials should remain sealed when not in use, and rubber stopper integrity should be maintained to prevent contamination. Once opened, multi-dose vials have specific beyond-use timeframes that should be followed. Your veterinarian will maintain appropriate storage for in-clinic use and provide guidance if injectable medication is dispensed for home use.

Oral formulations of ketoprofen, whether commercial tablets or compounded preparations, have their own storage requirements. Commercial tablets should be stored in original containers at room temperature, protected from moisture and light. Compounded oral suspensions typically require refrigeration and have shorter stability periods than commercial products. Always follow the specific storage instructions provided by the compounding pharmacy, including beyond-use dates which may be 30 to 90 days depending on the formulation.

Medication safety requires keeping all ketoprofen formulations securely stored and inaccessible to children and pets. Injectable solutions, in particular, should be stored in locations where accidental access is not possible. Rabbits are notorious chewers and should never have access to medication containers of any type. A locked cabinet, secure box, or high location in a room the rabbit cannot enter provides appropriate security.

Disposal of unused ketoprofen should follow local pharmaceutical disposal guidelines. Many communities have drug take-back programs that accept both human and veterinary medications. If no take-back program is available, injectable solutions and tablets can be mixed with undesirable substances and placed in sealed containers for household trash. Do not pour injectable solutions down drains or flush medications unless specifically directed by disposal guidelines. Compounded formulations should be disposed of according to the pharmacy's specific instructions.

Ketoprofen can be used in rabbits of all breeds when clinically indicated, without breed-specific contraindications or known differences in drug sensitivity based on breed. The medication works similarly across breed types, and therapeutic outcomes depend primarily on the underlying condition being treated and individual patient factors rather than breed characteristics. However, practical considerations related to size may influence dosing and administration approaches.

Dwarf breeds including Netherland Dwarfs, Holland Lops, Mini Rex, Polish rabbits, and similar small varieties require extremely careful dosing attention due to their small body size. These rabbits may weigh only 1 to 2 kg, meaning their ketoprofen doses are proportionally tiny. When injectable formulations are used, very small volumes must be accurately measured, often requiring specialized syringes. For oral preparations, compounded formulations are essentially required to allow accurate measurement. Dosing errors that might be tolerable in larger patients represent significant percentage variations in dwarf rabbits.

Giant breeds such as Flemish Giants, Continental Giants, French Lops, and similar large rabbits require larger total doses based on their greater body weight. While the dose per kilogram remains similar, the absolute amount of medication needed increases with body size. Giant breed rabbits receiving injectable ketoprofen will receive proportionally larger volumes. Despite their size, giant breeds remain sensitive to NSAID effects and require the same careful monitoring as smaller rabbits.

Lop-eared breeds do not have different sensitivity to ketoprofen compared to upright-eared rabbits from a pharmacological standpoint. However, lop rabbits are predisposed to ear infections due to their ear anatomy, and painful ear conditions are a common reason lop rabbits might require analgesic therapy. Comprehensive evaluation to identify all sources of pain, including potential ear involvement, ensures appropriate treatment planning.

Age-related factors affect ketoprofen suitability regardless of breed. Senior rabbits are more likely to have reduced kidney or liver function that increases sensitivity to NSAID adverse effects. Pre-treatment evaluation of organ function is particularly important in older rabbits. Very young rabbits have immature metabolic systems and may require modified dosing approaches. Your veterinarian will consider age alongside breed and size when determining appropriate ketoprofen therapy.

Several medications are related to or commonly used alongside ketoprofen for pain and inflammation management in rabbits. Understanding these alternatives provides context for treatment decisions and helps clarify when ketoprofen might be selected over other options. All medication choices should be made in consultation with your rabbit-savvy veterinarian.

Meloxicam (Metacam) is the first-line NSAID for rabbit use and remains the preferred anti-inflammatory pain medication for this species. Meloxicam has more extensive safety data in rabbits than other NSAIDs and is typically chosen unless specific reasons exist to select alternatives. Ketoprofen serves as an alternative when meloxicam is contraindicated, when injectable administration offers advantages, or in other specific circumstances determined by your veterinarian. Most rabbits requiring NSAID therapy will receive meloxicam rather than ketoprofen.

Carprofen (Rimadyl) is another NSAID used in veterinary medicine that may be considered for rabbit patients. Like ketoprofen, carprofen is considered a limited-use alternative to meloxicam in rabbits. Carprofen has well-established use in dogs and some clinical application in rabbits, though meloxicam generally remains preferred. The choice between ketoprofen and carprofen, when meloxicam is not suitable, depends on veterinary assessment of the individual situation.

Buprenorphine is an opioid pain medication that provides analgesia through different mechanisms than NSAIDs. Buprenorphine is valuable when anti-inflammatory medications are contraindicated, when stronger pain control is needed, or as part of multimodal analgesia combining opioid and NSAID medications for optimal pain management. Buprenorphine does not have the gastrointestinal or renal risks associated with NSAIDs, making it useful for patients who cannot receive anti-inflammatory therapy.

Tramadol is another analgesic option that works through opioid and other pain-modifying mechanisms. Tramadol may be considered for chronic pain conditions or situations where NSAID use needs to be minimized. The medication can be used alone or potentially in combination with reduced NSAID doses for multimodal pain management.

Non-pharmaceutical pain management approaches, including environmental modifications, physical therapy, laser therapy, and acupuncture, may complement or reduce the need for medication-based pain control. These approaches are particularly valuable for chronic painful conditions where minimizing long-term medication use is desirable. Your veterinarian can discuss comprehensive pain management strategies tailored to your rabbit's specific needs.